Hematology/Oncology Fellowship Kristie A. Blum, M.D. Gregory Otterson, M.D. The Ohio State University Department of Medicine, Division of Hematology & Oncology and The Comprehensive Cancer Center

ABIM Fellowship Requirements Hematology Board eligible – 2 year program Hematology Board eligible – 2 year program 12 months clinical service time 12 months clinical service time 12 months research 12 months research Laboratory or Clinical Laboratory or Clinical ½ day continuity clinic ½ day continuity clinic Oncology Board eligible – 2 year fellowship 12 months service time 12 months research Laboratory or Clinical ½ day continuity clinic Hematology/Oncology Board eligible (DUAL CERTIFICATION) – 2 year fellowship 18 months service time 18 months research Laboratory or Clinical ½ day continuity clinic

Research Opportunities Clinical Research Clinical Research Specific training in the design/writing of clinical trials Specific training in the design/writing of clinical trials Learn how to consent and enroll patients on trial, record toxicities, and analyze the data Learn how to consent and enroll patients on trial, record toxicities, and analyze the data Learn how to present and publish results/learn grant writing Learn how to present and publish results/learn grant writing Laboratory Research Laboratory Research Bench research: available in many areas (vascular biology/angiogenesis of tumors, genetic changes, cellular signaling changes, methods of tumor invasion, activity of new drugs, apoptosis/cell death, stem cell biology) Bench research: available in many areas (vascular biology/angiogenesis of tumors, genetic changes, cellular signaling changes, methods of tumor invasion, activity of new drugs, apoptosis/cell death, stem cell biology) Learn how to present and publish results/learn grant writing Learn how to present and publish results/learn grant writing Can combine both clinical and laboratory research – many clinical trials have a laboratory/translational component Can combine both clinical and laboratory research – many clinical trials have a laboratory/translational component MENTOR, MENTOR, MENTOR……. MENTOR, MENTOR, MENTOR…….

Fellowship requirements Heme/Onc board eligible – 3 year program Heme/Onc board eligible – 3 year program 18 months service time 18 months service time 3 months He2 3 months He2 2 months He1 2 months He1 2 months BMT 2 months BMT 3 months Onc2 3 months Onc2 3 months Consults 3 months Consults 1 month Hospice&PC 1 month Hospice&PC 1 month Heme path 1 month Heme path 0.5 month Blood bank 0.5 month Blood bank 2.5 months elective 2.5 months elective 18 months research 18 months research Med Onc board eligible – 2 year fellowship 12 months service time 2 months He2 1 months He1 1 months BMT 3 months Onc2 2 months Consults 1 month Hospice&PC 1 month Heme path 1 month elective 12 months research

Clinic schedule Heme/Onc board certified – 18 months Heme/Onc board certified – 18 months ½ day continuity for all 18 months ½ day continuity for all 18 months ½ day ambulatory clinic ½ day ambulatory clinic 6 months benign heme 6 months benign heme 3 months malignant heme 3 months malignant heme 3 months solid tumor 3 months solid tumor Med Onc certified – 12 months ½ day continuity for all 12 months ½ day ambulatory clinic 3 months malignant heme 3 months solid tumor

Protected time Heme/Onc – 18 months Heme/Onc – 18 months Clinical investigator pathway Clinical investigator pathway 2 – ½ day clinics per week 2 – ½ day clinics per week ½ day continuity ½ day continuity ½ day fellow’s choice ½ day fellow’s choice Complete CI training (includes writing protocol, LOI, grants, retrospective papers) Complete CI training (includes writing protocol, LOI, grants, retrospective papers) Laboratory investigator pathway Laboratory investigator pathway ½ day continuity clinic ½ day continuity clinic Laboratory training Laboratory training Med Onc – 12 months Clinical investigator pathway 2 – ½ day clinics per week ½ day continuity ½ day fellow’s choice Complete CI training (includes writing protocol, LOI, grants, retrospective papers) Laboratory investigator pathway ½ day continuity clinic Laboratory training

Practice Opportunities Academics Academics Mostly disease focused Mostly disease focused For example: Lung, GI, GU, Breast, Head and Neck, Endocrine, lymphoma, leukemia, myeloma focused For example: Lung, GI, GU, Breast, Head and Neck, Endocrine, lymphoma, leukemia, myeloma focused Some portion of protected time to conduct laboratory or clinical research or both Some portion of protected time to conduct laboratory or clinical research or both Somewhat less lucrative than private practice Somewhat less lucrative than private practice Benefits Benefits disease focus disease focus opportunity to do research opportunity to do research Interact with housestaff, fellows – can participate in education Interact with housestaff, fellows – can participate in education Share call with faculty, fellows, nurse practitioners Share call with faculty, fellows, nurse practitioners

Practice Opportunities Private practice Private practice Usually all malignancies Usually all malignancies Some practices do permit practitioners with some disease focus Some practices do permit practitioners with some disease focus Do usually have a few practitioners who see benign hematology, although not all members of the practice may be hematology certified Do usually have a few practitioners who see benign hematology, although not all members of the practice may be hematology certified Fairly Lucrative Fairly Lucrative Busy call and clinic schedule – frequent consults, cover own inpatients and consults, clinic 3-5 days/week Busy call and clinic schedule – frequent consults, cover own inpatients and consults, clinic 3-5 days/week Benefits Benefits Busy practice, opportunity to see many different malignancies Busy practice, opportunity to see many different malignancies Limited or no research, although many cancer centers participate in national pharmaceutical or co-operative group trials Limited or no research, although many cancer centers participate in national pharmaceutical or co-operative group trials Some educational opportunities Some educational opportunities

Professional Organizations American Society of Hematology American Society of Hematology Focuses on benign and malignant hematology Focuses on benign and malignant hematology Clinical and bench research Clinical and bench research American Society of Clinical Oncology American Society of Clinical Oncology Focuses primarily on solid tumors, although some representation of malignant hematology Focuses primarily on solid tumors, although some representation of malignant hematology Clinical and bench research Clinical and bench research Co-operative Groups Co-operative Groups CALGB, ECOG, SWOG – groups that conduct clinical trials at multiple sites CALGB, ECOG, SWOG – groups that conduct clinical trials at multiple sites